EAS Due Diligence Assessments Support Private Equity and Venture Capital Firms with Acquisitions in FDA and USDA Regulated Industries
News provided by
Share this article
Share this article
ALEXANDRIA, Va., March 17, 2021 /PRNewswire/ In the competitive FDA and USDA space, mergers and acquisitions of brands and companies lead to increased synergies and market share. Without careful and early due diligence assessments, however, these transactions can also increase exposure to regulatory risk. Having a clear and unbiased picture of the state of regulatory and quality compliance is a critical part of an overall due diligence assessment.
EAS Consulting Group s due diligence services support regulatory and compliance reviews of Private Equity (PE)/Venture Capital (VC) mergers and acquisitions. Our in-depth compliance, quality and regulatory risk assessments detail any gaps and necessary corrective actions, offering a complete and unbiased picture of regulatory and quality complianc